{"nct_id":"NCT01814839","title":"A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers","status":"COMPLETED","status_verified_date":"2016-02","start_date":"2013-03","start_date_type":null,"primary_completion_date":"2015-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ALNY"]}